The Impact of a Pharmaceutical Care Model on Improving Polycystic Ovary Syndrome

NACompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

March 1, 2017

Study Completion Date

July 30, 2017

Conditions
Polycystic Ovary Syndrome
Interventions
OTHER

The PCOS pharmaceutical care service

"The intervention was provided in the format of oral plus written information. The information provided included the importance of exercise and motivational messages to exercise more at home or in the gym.~The 2nd part was about the importance of decreasing the stress levels. Participants were informed to perform a simple breathing exercise on daily basis twice a day.~The 3rd part aimed at improving participants' diets. They were informed to follow specific diet recommendations and to avoid certain types of food, explaining to them how it may negatively affect their PCOS condition.~The 4th part was about the PCOS treatment that was discussed with the participants. Females were advised on the importance of using their correct treatment. They were informed of the importance of adhering to their prescribed medications, accepting that it was a long-term treatment plan, and to consult with their specialist if their treatment was not effective, or in the case of medication side effects."

Trial Locations (4)

Unknown

Five branches of Pharmacy 1, Amman

Almazra pharmacy, Damascus

Alwafaa pharmacy, Damascus

Kinda Pharmacy, Damascus

All Listed Sponsors
lead

Applied Science Private University

OTHER

NCT04416620 - The Impact of a Pharmaceutical Care Model on Improving Polycystic Ovary Syndrome | Biotech Hunter | Biotech Hunter